White papers: GxP regulated industry assessments of microplate readers and software

Written by Molecular Devices
Diagnostics and preclinical Drug discovery and development Lab design and machinery

Check out these White Papers for an overview of several key GxP Compliance references from the Code of Federal regulations Title 21 (21 CFR), relating to validation, good lab and manufacturing practices for clinical devices and pharmaceutical development, and data integrity in regulated environments.

Pick your way through the world of regulation clearly with the helpful guidelines in these two white papers.

 

In these White Papers, learn about: 

  • The FDA’s 21 CFR
  • Pharmaceutical drug development process
  • How the FDA reacts in case of non-compliance

And much more!

This content was provided by Molecular Devices.